I
IP Infusion
Leading provider of intelligent network software solutions for enhanced ip services
About IP Infusion
IP Infusion is a market leader in providing open network operating systems, primarily serving telecommunications companies, data centers, and enterprise networks. The company operates in the networking industry, focusing on software solutions that enable interoperability and scalability across various hardware platforms. IP Infusion's core product, OcNOS, is a disaggregated network operating system designed to run on low-cost commodity hardware, making it a cost-effective alternative to traditional, hardware-centric networking solutions. The business model revolves around licensing its software to clients, offering both subscription-based and perpetual licensing options. Revenue is generated through software sales, support services, and professional consulting. IP Infusion's solutions are recognized for their maturity, completeness, and field-tested reliability, making them a preferred choice for clients looking to modernize and optimize their network infrastructures.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 1999
- Headquarters
- Sunnyvale, United States
- Employees
- 499
- Open positions
- 6
- Dealroom signal
- 75.8/100
- Industry
- Telecom
- Sector
- Telecom, Network Hardware, Data Centers, Hard Tech
- Technology
- Hardware
- Client focus
- b2b
- Investment activity
- 1 company, latest Jul 2018
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Mar 2006 | $50M | $50M | Undisclosed | — |
| SERIES C✓Equity / VC | Apr 2002 | $15M | $59M | Intel Capital · Formative Ventures · ITX International Holdings · Pete Thomas | — |
Growth signals
Latest recorded traffic for IP Infusion is 23K monthly website visits, up 4.5% over the last three months. IP Infusion's team grew 43.8% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Pete Thomas
Yoshinari Yoshikawa
Bill Tai
IT-Farm
Series B and later4 investors entered at this stage
Formative Ventures
Intel Capital- IHITX International Holdings
Neoteny
Other known investors1 additional known investor
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about IP Infusion on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See IP Infusion’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









